← Back to all signals
RESEARCH PAPER ANALYSIS

Clinical characteristics and treatment evaluation of diffuse large B-cell lymphoma in Chinese children and adolescents: a multicenter clinical study of China-Net childhood lymphoma group B-NHL-2017.

AI interpretation is pending for this paper.

Open original publication →
PMID40694139
JournalJournal of cancer research and clinical oncology
Publication Date2025-07-22
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: China-Net Childhood Lymphoma (CNCL) group B-NHL-2017 study is a prospective multi-center study in China, with the purpose of standardizing the diagnosis and treatment of childhood lymphoma, and improving the prognosis. METHODS: From May 2017 to June 2023, 20 centers participated in the diffuse large B-cell lymphoma (DLBCL) study. The clinical data were analyzed to summarize the clinical characteristics, treatment response and outcome. The primary endpoint was 5-year event-free survival (EFS). The trial is registered with the Chinese Clinical Trial Registry (ChiCTR1800020067). RESULTS: A total of 138 children and adolescents were enrolled, including 101 males and 37 females. The median age of disease diagnosis was 9.0 years (range: 2.3-15.5 years). The range of follow-up time was 17 d-6.0 years. A total of 12 events occurred in this study, including 7 deaths. of which 4 patients died of disease and chemotherapy comorbidities (severe infection, septic shock, etc.), 1 died of disease progression (enlargement of the primary tumor and tumor metastasis), 1 died of recurrence, and 1 died of severe pneumonia in the third year after completing all chemotherapy courses. Recurrence occurred in 6 (4.3%) patients at 14.9 months (range: 4.4-32.6 months) after initial treatment. The 5-year overall survival (OS) was 90.7 ± 5.0% and the 5-year EFS was 85.5 ± 5.4%. Based on Cox regression analysis, no Rituximab during treatment is an independent risk factor for mortality in patients with DLBCL. CONCLUSION: The efficacy of CNCL-B-NHL-2017 protocol in the treatment of DLBCL in children and adolescents is close to results of international studies.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Pharmacological thromboprophylaxis following ventriculoperitoneal shunt insertion: a single-centre experience of thromboembolic and bleeding outcomes. Acta neurochirurgica 66.5 2 Design principles of prosthetic reconstruction after pelvic tumor resection: a systematic review and perspective from modular systems to 3D-printed personalized solutions. Journal of orthopaedic surgery and research 73.9 3 Ultrasound-guided versus conventional sinus tract laser closure for adolescent sacrococcygeal pilonidal disease: a retrospective comparative study. Techniques in coloproctology 68.4 4 Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy. Journal of clinical immunology 56.0 5 A qualitative exploration of the psychosocial burden and coping among adolescents and young adults with hematologic malignancies. BMC cancer 64.1 6 Preliminary Psychometric Evaluation of an Ultraviolet Radiation-Related Questionnaire in a Case-Control Sample. Ocular oncology and pathology 70.4 7 Forty Years Later-Complications and Mortality Associated with Cultured Epithelial Autografts in Burn Patients: A Systematic Review. Bioengineering (Basel, Switzerland) 78.1 8 Early Cardiotoxicity in Pediatric Patients with Acute Lymphoblastic Leukemia and Hodgkin Lymphoma: Incidence, Risk Factors, and Clinical Implications. Children (Basel, Switzerland) 74.62 9 Evaluating the Role of Anti-PEG Antibodies in Hypersensitivity to PEG-Asparaginase Through Clinically Relevant Cut-Points Defined by ELISA and Surface Plasmon Resonance. Pharmaceutics 62.0 10 Pediatric Microbiota: Evidence and Future Perspectives-A Conference Report. Microorganisms 65.0 11 A Bias-Aware Analytic Framework for Real-World Data with AI-Audited Workflows: Application to Opioid Ordering in Pediatric Oncology. Bioengineering (Basel, Switzerland) 73.2 12 All-Trans Retinoic Acid Nanocrystals for Enhanced Anticancer Activity Against Neuroblastoma Cancer Stem Cells. Pharmaceutics 53.3 13 Contribution of MTHFR C677T and A1298C Variants to Retinoblastoma Risk in Mexican Children. Genes 64.5 14 EBUS-Guided Cryobiopsy in a Pediatric Inflammatory Mediastinal Tumor With ROS1 Fusion: A Case Report. Pediatric pulmonology 39.0 15 Epidemiology of Kaposi's Sarcoma in Uzbekistan, 2016-2024: Gender-, Age-, and Region-Specific Differences. Asian Pacific journal of cancer prevention : APJCP 37.0 16 Design and Validation of Evidence-Based Peripheral Chemotherapy-Induced Neuropathy Guideline Among the Children with Cancer. Asian Pacific journal of cancer prevention : APJCP 75.34 17 Institutional and Demographic Barriers to Cervical Cancer Screening among Women in Rivers State, Nigeria. Asian Pacific journal of cancer prevention : APJCP 59.5 18 Endoscopic endonasal management of giant pediatric craniopharyngioma. Neurosurgical focus: Video 54.0 19 Keyhole endoscopic resection of pediatric craniopharyngioma via a precoronal transventricular transforaminal approach: "small door, big win.": Two-dimensional operative video. Neurosurgical focus: Video 54.0 20 Subpial dissection technique in endoscopic endonasal surgery for craniopharyngiomas with supradiaphragmatic extension. Neurosurgical focus: Video 35.0 21 Modern craniopharyngioma management: three illustrative cases with distinct therapeutic strategies. Neurosurgical focus: Video 62.04 22 Management of a giant pediatric craniopharyngioma: staged endoscopic endonasal and cranial approaches. Neurosurgical focus: Video 54.0 23 Excision of pediatric craniopharyngioma with complicated features: the value of additional "tailored" cavernous sinus exposure in the standard pterional approach. Neurosurgical focus: Video 56.4 24 Incidental Mandibular Intraosseous Findings in Neurofibromatosis Type 1: CBCT and MRI Features Influencing Clinical Management. Nigerian journal of clinical practice 60.8 25 Mitochondria as Key Players in Sarcoma Development, Progression and Drug Resistance: From Mechanistic Insights to New Treatment Opportunities. Biomolecules 70.6 26 Anodal Transcranial Direct Current Stimulation Reduces Neuroinflammation and Cholinergic Dysregulation After Young Adult Traumatic Brain Injury. Biomolecules 41.7 27 The Antigen-Presentation Bottleneck in Pediatric Solid Tumors: Developmental Antigens, MHC-I Suppression, and Therapeutic Restoration of Tumor Immune Recognition. Biomolecules 66.44 28 Factors Associated with Ventriculoperitoneal Shunt Placement Following Posterior Fossa Tumor Resection in Children: A Systematic Review and Meta-Analysis. Medicina (Kaunas, Lithuania) 75.0 29 Clinical outcomes and prognostic factors in pediatric acute myeloid leukemia with monocytic differentiation: a single-center cohort study from Egypt. Frontiers in oncology 77.8 30 Multi-cohort screening of PANoptosis-related genes reveals PARP1 as a key target, and AZD5305 exerts anti-tumor effects in neuroblastoma. Frontiers in oncology 62.2 31 Extensive vertebral compression fractures as the initial manifestation of childhood B-cell acute lymphoblastic leukemia despite limited peripheral blood abnormalities: a case report. Frontiers in pediatrics 51.4 32 Cervical cancer screening willingness and associated health beliefs among predominantly college-educated young women attending gynecology clinics in Shenzhen, China. Frontiers in public health 59.0
PATIENT-FRIENDLY SUMMARY

Clinical characteristics and treatment evaluation of diffuse large B-cell lymphoma in Chinese children and adolescents: a multicenter clinical study of China-Net childhood lymphoma group B-NHL-2017.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic